Optimi Health Corp. (NASDAQ:OPTH – Get Free Report) was the target of a large drop in short interest during the month of July. As of July 31st, there was short interest totaling 20,776 shares, a drop of 71.2% from the July 15th total of 72,205 shares. Currently, 0.4% of the company’s shares are short sold. Based on an average daily trading volume, of 34,203 shares, the short-interest ratio is presently 0.6 days.
Optimi Health Trading Down 0.8%
NASDAQ OPTH traded down $0.04 during trading hours on Friday, reaching $4.79. The company had a trading volume of 23,229 shares, compared to its average volume of 27,536. The company has a debt-to-equity ratio of 0.04, a current ratio of 0.06 and a quick ratio of 0.03. The company has a market capitalization of $27.45 million and a PE ratio of -13.31. The firm has a 50-day moving average price of $4.69. Optimi Health has a 1-year low of $4.00 and a 1-year high of $6.40.
Wall Street Analysts Forecast Growth
OPTH has been the topic of several analyst reports. Wall Street Zen raised shares of Optimi Health to a “hold” rating in a research report on Saturday, July 25th. Weiss Ratings initiated coverage on Optimi Health in a research note on Thursday, May 21st. They set a “sell (d-)” rating for the company. Finally, Zacks Research upgraded Optimi Health to a “hold” rating in a research report on Thursday, May 28th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Reduce”.
Optimi Health Company Profile
Optimi Health Corp. is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies. Optimi Health Corp. is based in VANCOUVER, BC.
Recommended Stories
- Five stocks we like better than Optimi Health
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Optimi Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Optimi Health and related companies with MarketBeat.com's FREE daily email newsletter.
